Neuropsychological Functioning in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitor Therapy

被引：0
|
作者：
Weaver, J. R.
Stark, S. M.
Shaverdi, K. T.
Jeter, S.
Zorzi, J.
Skolasky, R. L.
Andrejczuk, M. A.
Sterans, V
Gordon, B.
机构：
来源：
CLINICAL NEUROPSYCHOLOGIST | 2011年 / 25卷 / 05期
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：883 / 883
页数：1
相关论文
共 50 条
  • [41] Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients
    Crew K.D.
    Capodice J.L.
    Greenlee H.
    Apollo A.
    Jacobson J.S.
    Raptis G.
    Blozie K.
    Sierra A.
    Hershman D.L.
    Journal of Cancer Survivorship, 2007, 1 (4) : 283 - 291
  • [42] Safety of adjuvant aromatase inhibitor therapy
    Venturini, M.
    Del Mastro, L.
    CANCER TREATMENT REVIEWS, 2006, 32 (07) : 548 - 556
  • [43] Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant radiation and tamoxifen
    Freedman, Gary M.
    Anderson, Penny
    Li, Tianyu
    Ross, Eric
    Swaby, Ramona
    Goldstein, Lori
    CANCER, 2006, 107 (11) : 2552 - 2558
  • [44] Appraising adjuvant aromatase inhibitor therapy
    Perez, Edith A.
    ONCOLOGIST, 2006, 11 (10): : 1058 - 1069
  • [45] Quality of life assessment in patients receiving adjuvant therapy for breast cancer
    Bernhard, J
    Hurny, C
    Peterson, HF
    Gelber, RD
    CastiglioneGertsch, M
    Coates, AS
    QUALITY OF LIFE RESEARCH, 1997, 6 (7-8) : 36 - 36
  • [46] Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole
    Sun, Shengliang
    Wang, Fuchao
    Dou, Honglei
    Zhang, Longqiang
    Li, Jiwen
    ONCOTARGETS AND THERAPY, 2016, 9 : 6029 - 6036
  • [47] Tamoxifen or aromatase inhibitors: which one is the culprit of urinary incontinence in premenopausal breast cancer patients receiving adjuvant hormone therapy?
    Kubilay Karaboyun
    Eyyup Cavdar
    Yakup Irıagac
    Abdussamet Celebı
    Tanju Kapagan
    Ilkay Gulturk
    Ozden Demır
    Okan Avcı
    Erdogan Selcuk Seber
    Supportive Care in Cancer, 2023, 31
  • [48] STUDY OF DNA GAINS AND LOSSES IN TUMOURS OF BREAST CANCER (BC) PATIENTS RECEIVING NEO-ADJUVANT AROMATASE INHIBITOR (AI) TREATMENT
    Knowles, E. Lopez
    Anderson, H.
    Mackay, A.
    Ghazoui, Z.
    Larionov, A.
    Miller, W. R.
    Dixon, M.
    Reis-Filho, J. S.
    Dowsett, M.
    Dunbier, A. K.
    ANNALS OF ONCOLOGY, 2011, 22 : 44 - 45
  • [49] Tamoxifen or aromatase inhibitors: which one is the culprit of urinary incontinence in premenopausal breast cancer patients receiving adjuvant hormone therapy?
    Karaboyun, Kubilay
    Cavdar, Eyyup
    Iriagac, Yakup
    Celebi, Abdussamet
    Kapagan, Tanju
    Gulturk, Ilkay
    Demir, Ozden
    Avci, Okan
    Seber, Erdogan Selcuk
    SUPPORTIVE CARE IN CANCER, 2023, 31 (06)
  • [50] Endocrine therapy after aromatase inhibitor therapy in breast cancer
    Verma, Mohit K.
    Miki, Yasuhiro
    Sasano, Hironobu
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2011, 6 (03) : 309 - 312
12345